William G. Kaelin, Jr.
16Patents
4h-index
11Co-inventors
57Inventor score
Filing activity: May 13, 1992 → Sep 13, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6849718B2 | Muteins of hypoxia inducible factor alpha and methods of use thereof | Physics | 22 | Expired |
| US6855510B2 | Pharmaceuticals and methods for treating hypoxia and screening methods therefor | Physics | 22 | Expired |
| US7176345B2 | Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor | Physics | 7 | Expired |
| US5759803A | Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA | Chemistry; Metallurgy | 5 | Expired |
| US7985563B2 | HIFαprolyl hydroxylation assay | Physics | 3 | Active |
| US6451979B1 | Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7919274B2 | Light-emitting fusion proteins and diagnostic and therapeutic methods therefor | Physics | 3 | Expired |
| US8809011B2 | HIFα hydroxylation assay | Physics | 2 | Active |
| US7361463B2 | Muteins of hypoxia inducible factor alpha and methods of use thereof | Physics | 2 | Expired |
| US10233452B2 | Compositions and methods for increasing erythropoietin (EPO) production | Chemistry; Metallurgy | 0 | Active |
| US9766240B2 | Method of identifying a compound for treating a hypoxic or ischemic related disorder | Physics | 0 | Active |
| US9193973B2 | Compositions and methods for increasing erythropoietin (EPO) production | Chemistry; Metallurgy | 0 | Active |
| US10365278B2 | Pharmaceuticals and methods for treating hypoxia and screening methods therefor | Physics | 0 | Active |
| US7666997B2 | Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11340216B2 | Methods and compositions for the positive selection of protein destabilizers | Physics | 0 | Active |
| US5981723A | Retinoblastoma-associated protein 1 CDNA | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.